Activation of the nuclear transcription factor κB (NFκB) and differential gene expression in U87 glioma cells after exposure to the cytoprotector amifostine

[1]  R. Weichselbaum,et al.  Inhibition of spontaneous metastases formation by amifostine , 2002, International journal of cancer.

[2]  D. Hallahan,et al.  Activation of NFκB and MnSOD gene expression by free radical scavengers in human microvascular endothelial cells , 2001 .

[3]  Chris Albanese,et al.  NF-κB and cell-cycle regulation: the cyclin connection , 2001 .

[4]  C. Bever,et al.  Glatiramer acetate blocks interleukin-1-dependent nuclear factor-kappaB activation and RANTES expression in human U-251 MG astroglial cells. , 2001, Brain research. Molecular brain research.

[5]  L. MacMillan-Crow,et al.  Manganese superoxide dismutase in disease , 2001, Free radical research.

[6]  D. Murray,et al.  Protection of Human Tumor Cells of Differing Radiosensitivity by WR-1065 , 2000, Radiation research.

[7]  P. Tassone,et al.  Amifostine inhibits hematopoietic progenitor cell apoptosis by activating NF-kappaB/Rel transcription factors. , 1999, Blood.

[8]  H. Pahl.  Activators and target genes of Rel/NF-κB transcription factors , 1999, Oncogene.

[9]  T. Thomas,et al.  Activation of nuclear factor kappaB by polyamines in breast cancer cells. , 1999, Biochemistry.

[10]  L. Oberley,et al.  Overexpression of manganese superoxide dismutase in DU145 human prostate carcinoma cells has multiple effects on cell phenotype , 1998, The Prostate.

[11]  G. Woloschak,et al.  Repression of c-myc gene expression by the thiol and disulfide forms of the cytoprotector amifostine. , 1997, Carcinogenesis.

[12]  A. Guillouzo,et al.  Oltipraz stimulates the transcription of the manganese superoxide dismutase gene in rat hepatocytes. , 1997, Carcinogenesis.

[13]  C. White,et al.  Activation of NF-kappaB by antineoplastic agents. Role of protein kinase C. , 1997, The Journal of biological chemistry.

[14]  A. Constantinou,et al.  WR‐1065, an active metabolite of the cytoprotector amifostine, affects phosphorylation of topoisomerase IIα leading to changes in enzyme activity and cell cycle progression in CHO AA8 cells , 1997, Cell proliferation.

[15]  L. Oberley,et al.  Transfection and expression of MnSOD cDNA decreases tumor malignancy of human oral squamous carcinoma SCC-25 cells. , 1997, Human gene therapy.

[16]  C. Sen,et al.  Antioxidant and redox regulation of gene transcription , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  C. White,et al.  Activation of NF-kappa B and elevation of MnSOD gene expression by thiol reducing agents in lung adenocarcinoma (A549) cells. , 1995, The American journal of physiology.

[18]  N. Shigematsu,et al.  Thiol and disulfide metabolites of the radiation protector and potential chemopreventive agent WR-2721 are linked to both its anti-cytotoxic and anti-mutagenic mechanisms of action. , 1995, Carcinogenesis.

[19]  J. Sedivy,et al.  Effects of c-myc expression on cell cycle progression , 1994, Molecular and cellular biology.

[20]  D. S. St. Clair,et al.  Suppression of fibrosarcoma metastasis by elevated expression of manganese superoxide dismutase. , 1994, Cancer research.

[21]  C. Welter,et al.  The cellular myb oncogene is amplified, rearranged and activated in human glioblastoma cell lines. , 1990, Cancer letters.

[22]  H. Wieand,et al.  Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. , 1989, Cancer research.

[23]  T. Schall,et al.  A human T cell-specific molecule is a member of a new gene family. , 1988, Journal of immunology.

[24]  J. Ward,et al.  Radioprotection of cells in culture by WR-2721 and derivatives: form of the drug responsible for protection. , 1988, Cancer research.

[25]  T. Schall,et al.  The isolation and sequence of a novel gene from a human functional T cell line , 1987, The Journal of experimental medicine.

[26]  T. Waldmann,et al.  The human interleukin-2 receptor: normal and abnormal expression in T cells and in leukemias induced by the human T-lymphotropic retroviruses. , 1986, Annals of internal medicine.

[27]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[28]  Y. Kataoka,et al.  Cytoprotection by WR-1065, the active form of amifostine, is independent of p53 status in human malignant glioma cell lines. , 2000, International journal of radiation biology.

[29]  Y. Kataoka,et al.  Amifostine: Mechanisms of Action Underlying Cytoprotection and Chemoprevention , 2000, Drug metabolism and drug interactions.

[30]  L. Packer,et al.  Redox regulation of NF-kappa B activation. , 1997, Free radical biology & medicine.

[31]  P. Baeuerle,et al.  NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules. , 1997, Advances in immunology.

[32]  P. Baeuerle,et al.  Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.

[33]  W. Leonard,et al.  The human interleukin-2 receptor. , 1986 .